Begin typing your search above and press return to search.
US Might Supply Pandemic Vaccine To Other Nations: Donald Trump
By: Tupaki Desk | 29 July 2020 1:50 PM GMT
United States President Donald Trump, who recently called for a press briefing to discuss the situation post-pandemic outbreak in the nation made some crucial remarks on pandemic vaccines.
Donald Trump sounded a bit confident that the United States might supply the potential vaccine that can cure the ongoing pandemic to other nations, once the vaccine is made available.
Trump maintained that once the vaccine gets ready, it will be supplied in the entire country and will be supplied to other countries as well, just like the way the United States dealt with the ventilators.
Earlier, the National Institutes of Health (NIH) claimed that the scientists started the third phase of the clinical trial of the pandemic vaccine and are confident about the vaccine. The vaccine is being developed by American biotechnology company Moderna.
The scientists are gearing up to conduct the third phase of the clinical trial with as many as 30,000 volunteers to derive the accurate impact of the potential vaccine. All volunteers are adults.
The Trump Administration is not leaving any stone unturned to see that the potential vaccine will be made ready by the end of 2020 or early 2021.
Donald Trump sounded a bit confident that the United States might supply the potential vaccine that can cure the ongoing pandemic to other nations, once the vaccine is made available.
Trump maintained that once the vaccine gets ready, it will be supplied in the entire country and will be supplied to other countries as well, just like the way the United States dealt with the ventilators.
Earlier, the National Institutes of Health (NIH) claimed that the scientists started the third phase of the clinical trial of the pandemic vaccine and are confident about the vaccine. The vaccine is being developed by American biotechnology company Moderna.
The scientists are gearing up to conduct the third phase of the clinical trial with as many as 30,000 volunteers to derive the accurate impact of the potential vaccine. All volunteers are adults.
The Trump Administration is not leaving any stone unturned to see that the potential vaccine will be made ready by the end of 2020 or early 2021.
